X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Merck Ltd with Abbott India - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

MERCK LTD vs ABBOTT INDIA - Comparison Results

MERCK LTD    Change

Merck, the Indian arm of Merck KgaA (Germany), is a relatively smaller player among MNC pharma majors in the country. Merck has two business segments namely Pharmaceuticals and Chemicals. The pharmaceutical business, accounting for 68% of total sales... More

ABBOTT INDIA 
   Change

Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmace... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    MERCK LTD ABBOTT INDIA MERCK LTD/
ABBOTT INDIA
 
P/E (TTM) x 25.4 32.8 77.5% View Chart
P/BV x 2.8 8.2 34.7% View Chart
Dividend Yield % 1.0 0.8 121.3%  

Financials

 MERCK LTD   ABBOTT INDIA
EQUITY SHARE DATA
    MERCK LTD
Dec-16
ABBOTT INDIA
Mar-16
MERCK LTD/
ABBOTT INDIA
5-Yr Chart
Click to enlarge
High Rs1,0606,015 17.6%   
Low Rs6233,707 16.8%   
Sales per share (Unadj.) Rs632.41,236.9 51.1%  
Earnings per share (Unadj.) Rs45.7122.2 37.4%  
Cash flow per share (Unadj.) Rs62.3129.0 48.3%  
Dividends per share (Unadj.) Rs11.0035.00 31.4%  
Dividend yield (eoy) %1.30.7 181.5%  
Book value per share (Unadj.) Rs388.8521.2 74.6%  
Shares outstanding (eoy) m16.6021.25 78.1%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.33.9 33.9%   
Avg P/E ratio x18.439.8 46.3%  
P/CF ratio (eoy) x13.537.7 35.8%  
Price / Book Value ratio x2.29.3 23.2%  
Dividend payout %24.128.6 84.0%   
Avg Mkt Cap Rs m13,969103,296 13.5%   
No. of employees `0001.63.0 53.6%   
Total wages/salary Rs m1,4873,370 44.1%   
Avg. sales/employee Rs Th6,631.98,891.8 74.6%   
Avg. wages/employee Rs Th939.21,140.0 82.4%   
Avg. net profit/employee Rs Th479.4878.3 54.6%   
INCOME DATA
Net Sales Rs m10,49826,284 39.9%  
Other income Rs m242504 48.1%   
Total revenues Rs m10,74126,789 40.1%   
Gross profit Rs m1,1353,665 31.0%  
Depreciation Rs m276144 190.8%   
Interest Rs m08 0.0%   
Profit before tax Rs m1,1024,017 27.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m3431,421 24.2%   
Profit after tax Rs m7592,596 29.2%  
Gross profit margin %10.813.9 77.5%  
Effective tax rate %31.135.4 88.1%   
Net profit margin %7.29.9 73.2%  
BALANCE SHEET DATA
Current assets Rs m6,41014,446 44.4%   
Current liabilities Rs m8,8284,725 186.9%   
Net working cap to sales %-23.037.0 -62.3%  
Current ratio x0.73.1 23.7%  
Inventory Days Days5851 112.2%  
Debtors Days Days3820 196.3%  
Net fixed assets Rs m1,4061,113 126.4%   
Share capital Rs m166213 78.1%   
"Free" reserves Rs m6,28610,808 58.2%   
Net worth Rs m6,45511,076 58.3%   
Long term debt Rs m00-   
Total assets Rs m8,82816,241 54.4%  
Interest coverage xNM497.0-  
Debt to equity ratio x00-  
Sales to assets ratio x1.21.6 73.5%   
Return on assets %8.616.0 53.6%  
Return on equity %11.823.4 50.2%  
Return on capital %17.136.3 47.0%  
Exports to sales %8.30.6 1,347.0%   
Imports to sales %21.012.6 166.5%   
Exports (fob) Rs m869162 538.0%   
Imports (cif) Rs m2,2093,322 66.5%   
Fx inflow Rs m959268 357.8%   
Fx outflow Rs m2,6123,927 66.5%   
Net fx Rs m-1,653-3,659 45.2%   
CASH FLOW
From Operations Rs m1,0702,514 42.6%  
From Investments Rs m-750-800 93.8%  
From Financial Activity Rs m-150-803 18.7%  
Net Cashflow Rs m171912 18.7%  

Share Holding

Indian Promoters % 0.0 0.0 -  
Foreign collaborators % 51.8 75.0 69.1%  
Indian inst/Mut Fund % 18.2 7.9 230.4%  
FIIs % 1.0 0.1 1,000.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 29.1 17.1 170.2%  
Shareholders   28,591 18,270 156.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare MERCK LTD With:   ALKEM LABORATORIES  PLETHICO PHARMA  WOCKHARDT LTD.  TORRENT PHARMA  ALEMBIC LTD  

Compare MERCK LTD With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Trades in Red; Dr Reddy's Jumps 6%(01:30 pm)

After opening the day marginally in green, share markets in India have reversed the trend and are trading in red. Sectoral indices are trading on a mixed note with stocks in the pharma sector.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

India's Big and Messy Real Estate Ponzi Scheme, Just Got Messier(Vivek Kaul's Diary)

Sep 11, 2017

The question is, whether real estate buyers are financial creditors or not.

The Recipe to Over 60% Returns in Less Than a Year(The 5 Minute Wrapup)

Sep 9, 2017

Short term crisis in some companies could unveil some great investing opportunities.

Feeling Left Out? Two Opportunities to Make Money in This Market(Daily Profit Hunter)

Sep 13, 2017

Nifty is above 10,000 once again. Have you missed the bus?

Introducing Smart Contrarian: The Blueprint for Big Profits from Small Investments

Sep 18, 2017

Welcome to a bold, new initiative designed for the truly contrarian investor.

How To Link Aadhaar With Your Mutual Fund Investments(Outside View)

Sep 11, 2017

The Government has extended the linking of the unique Aadhaar number to nearly all financial transactions.

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

MERCK LTD SHARE PRICE


Sep 21, 2017 02:05 PM

TRACK MERCK LTD

  • Track your investment in MERCK LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MERCK LTD - CIPLA COMPARISON

COMPARE MERCK LTD WITH

MARKET STATS